ondansetron has been researched along with Cerebellar Ataxia in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Cerebellar Ataxia: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mandelcorn, J | 1 |
| Cullen, NK | 1 |
| Bayley, MT | 1 |
1 trial available for ondansetron and Cerebellar Ataxia
| Article | Year |
|---|---|
A preliminary study of the efficacy of ondansetron in the treatment of ataxia, poor balance and incoordination from brain injury.
Topics: Adult; Brain Injury, Chronic; Cerebellar Ataxia; Female; Humans; Male; Middle Aged; Neuropsychologic | 2004 |